June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Effect of intraviteal injection of AAV9.TGFβ2 on the expression of anterior segment and intraocular pressure in rabbits
Author Affiliations & Notes
  • Guilin Zhan
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Chris Long
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Allan Shepard
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Nasreen Jacobson
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Richard Ornberg
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Yu Wang
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Shutong Cao
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Ganesh Prasanna
    Ophthalmology Res./Glaucoma Res., Novartis Institutes for Biomedical Res., Fort Worth, TX
  • Footnotes
    Commercial Relationships Guilin Zhan, Novartis Institution for Biomedical Research (E); Chris Long, None; Allan Shepard, None; Nasreen Jacobson, Novartis Institute Biomedical Res (E); Richard Ornberg, Novartis Institute for Biomedical Research (E); Yu Wang, None; Shutong Cao, nibr (E); Ganesh Prasanna, Alcon Research Ltd (E), Novartis Institute of Biomedical Research (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2719. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Guilin Zhan, Chris Long, Allan Shepard, Nasreen Jacobson, Richard Ornberg, Yu Wang, Shutong Cao, Ganesh Prasanna; Effect of intraviteal injection of AAV9.TGFβ2 on the expression of anterior segment and intraocular pressure in rabbits. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2719. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: TGFβ2 levels are elevated in aqueous humor (AH) of primary open angle glaucoma patients and have been associated with ultrastructural changes to trabecular meshwork (TM) leading to elevated intraocular pressure (IOP). This study is to explore viral transduction and overexpression of TGFβ2 on IOP in New Zealand rabbits.

Methods: Eight rabbits received unilateral intravitreal injection of 50µl of AAV9-mut446-sc-smCBA-hTGFβ2 (1.25E12 vg/mL) and other four received AAV9-mut446-sc-smCBA-hGFP (6.4E12 vg/mL). The injections were repeated one week following the initial injection. IOP was measured at day 0 and once or twice per week using a pneumatonometer on day 6-62 post second-injection. Ocular inflammation including flare, cells and fibrin in anterior chamber and GFP expression were examined by slit lamp (SL) beginning one day after injection. The expression of GFP in the anterior segment of rabbits was assessed by immunohistochemistry (IHC). Total and bioactive TGFβ2 in rabbit AH were detected by ELISA 62 days post-injection.

Results: GFP expression was detected in 75% of four AAV9.GFP treated rabbits by SL beginning 14 days post-injection and 50% of these injected eyes showed a positive expression of GFP at 49 and 62 days post-injection by IHC in anterior segment of eye. Compared with uninjected (UI) eyes, total TGFβ2 in AH showed an increasing trend (P=0.1) in AAV9.TGFβ2 (2314 ± 316 vs UI eye: 1664 ± 198 pg/mL), while was significantly different in AAV9.GFP treated group (2412 ± 246 vs UI eye: 1972 ± 185 pg/mL; p=0.035). Bioactive TGFβ2 levels in AAV9.TGF β2 eyes were 41 ± 9 pg/mL (UI eye: 42 ± 9 pg/mL) while that in AAV9.GFP eyes was 16 ± 8 pg/mL (UI eye: 41 ± 21 pg/mL). No statistically significant difference in total and bioactive TGFβ2 levels were found between AAV9.TGFβ2 and AAV9.GFP injected groups. Inflammation could be detected in 50% of eyes in both groups lasting for 2-3 weeks. Compared with pre-injection baseline, IOP was not significantly increased in either AAV9.TGFβ2 (BL: 20 ± 0.8 mmHg; Day 62: 23 ± 0.5 mmHg) or AAV9.GFP treated eyes (BL: 17 ± 0.5 mmHg; Day 62: 19 ± 1.5 mmHg).

Conclusions: Our results indicate that AAV9.GFP can be transduced in the ocular anterior segment of rabbits. However, TGFβ2 levels in AH did not result in elevated IOP in rabbits and could be due to species differences and/or insufficient expression of TGFβ2 with these vectors.

Keywords: 538 gene transfer/gene therapy • 421 anterior segment • 568 intraocular pressure  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×